Meta facebook tracking pixel

Listen Now

Topics Covered

  • Novel Therapy for Adjuvant Hormone Receptor Positive Breast Cancer
  • Antibody Drug Conjugates in First Line Metastatic Hormone Receptor Positive Breast Cancer
  • Tailoring First Line Therapy in Metastatic HER2 Positive Breast Cancer
  • Integration & Sequencing of Novel Oral Selective Estrogen Receptor Degraders (SERDs) in Metastatic Hormone Receptor Positive Breast Cancer
  • Deescalating Therapy in Low-Risk Ductal Carcinoma In Situ (DCIS)
  • Questions for Our Panel of Experts

Our Panel of Experts

Presenter

Kate Lathrop, MD

Associate Professor, Division of Hematology and Oncology, UT Health San Antonio, Breast Medical Oncology, Mays Cancer Center at UT Health San Antonio, Assistant Dean of Undergraduate Research, Long School of Medicine, UT Health San Antonio, Program Director, Medical Oncology and Hematology Fellowship Program, UT Health San Antonio, Program Director, San Antonio Breast Cancer Symposium (SABCS)

Presenter

Kamel Abou Hussein, MD

Assistant Professor of Medicine, Cooper Medical School of Rowan University, Adjunct Assistant Professor, Department of Breast Medical Oncology, MD Anderson Cancer Center, Co-Director of the Janet Knowles Breast Cancer Program, Director of Breast Cancer Clinical Trials, MD Anderson Cancer Center at Cooper

Presenter

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on December 17, 2025.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top